Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1424029

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1424029

Australia Facial Injectables Market Share, Size, Trends, Industry Analysis Report, By Procedure Type, By Application (Aesthetics, Therapeutics), And Segment Forecasts, 2024 - 2032

PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The global Australia facial injectable market size is expected to reach USD 17.36 billion by 2032, according to a new study by Polaris Market Research. The report "Australia Facial Injectables Market Share, Size, Trends, Industry Analysis Report, By Procedure Type, By Application (Aesthetics, Therapeutics), And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis of future market growth.

Dermatologists and other professionals can address diverse facial areas, tailor treatments for individual patients, and employ a combination of products to achieve enhanced results. Millennials' choices in purchasing are notably swayed by peer recommendations, with a considerable influence stemming from social media. According to the 2020 Yellow Social Media Report, 63% of Australians indicated that endorsements from celebrities or social media influencers negatively impact their likelihood of making a purchase, whereas 15% reported the opposite effect.

Facial injectables find application in diminishing wrinkles and fine lines, adding volume and contouring, and establishing facial framework and structure. The anticipated growth in the industry is expected to be propelled by an increasing awareness of cosmetic procedures and the growing elderly population. Furthermore, advancements in facial rejuvenation and the shift in trends from invasive to minimally invasive procedures are additional factors foreseen to drive market growth.

Dermal fillers, often containing substances like hyaluronic acid, are utilized to restore volume, smooth out wrinkles, and enhance facial contours. They can be particularly effective in addressing issues like hyperpigmentation by providing a rejuvenated and even skin tone. Neuromodulators, such as botulinum toxin, are employed to temporarily relax muscles, reducing the appearance of fine lines and wrinkles. This not only helps in preventing the formation of new lines but also addresses early signs of aging, contributing to a more youthful appearance. The rising demand for facial injectables reflects a broader cultural shift towards non-invasive and non-surgical cosmetic procedures, driven by a desire for effective anti-aging solutions with minimal downtime. This trend underscores the integral role that facial injectables play in the contemporary landscape of aesthetic enhancement.

The surge in internet consultations was a notable outcome of the COVID-19 outbreak. Australia implemented a comprehensive temporary shutdown of beauty and cosmetic services as a preventive measure against COVID-19. The Centre for Mental Health at Swinburne University has been engaged in researching the impact of the beauty business closure on the mental health of Australians. The study revealed that, in comparison to the period before COVID-19, the general population expressed reduced interest in undergoing cosmetic surgery or treatments following the conclusion of the initial lockdown. This shift in interest subsequently affected the demand for facial injectables.

Australia Facial Injectables Market Report Highlights

Botulinum type A segment held the largest revenue share, owing to its high success rate and increasing concerns among people to look young

The hyaluronic acid segment will grow significantly, owing to its ability to recede down the epidermis and moisturize skin glands

The therapeutics segment will grow rapidly, primarily due to a rise in non-invasive aesthetic procedures and innovations in drug formulations

The market players include SILK Laser Clinics, Results Laser Clinic, Australian Skin Clinics, Advanced Clinics Australia, and Laser Clinics Australia

Polaris Market Research has segmented the Australia facial injectables market report based on procedure type, application, and region:

Australia Facial Injectables, Procedure Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Collagen
  • Hyaluronic Acid (HA)
  • Botulinum Toxin Type A
  • Calcium Hydroxylapatite (CaHA)
  • Polymer Fillers
  • Polymethylmethacrylate Microspheres (PMMA)
  • PLLA (Poly-L-lactic acid)

Australia Facial Injectables, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Aesthetics
  • Therapeutics
Product Code: PM4330

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Australia Facial Injectables Market Insights

  • 4.1. Australia Facial Injectables Market - Industry Snapshot
  • 4.2. Australia Facial Injectables Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rise in establishments of MediSpas in Australia
      • 4.2.1.2. Advancements in facial injectables
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Associated side effects
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Australia Facial Injectables Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Australia Facial Injectables Market, by Procedure Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Australia Facial Injectables, by Procedure Type, 2019-2032 (USD Billion)
  • 5.3. Collagen
    • 5.3.1. Australia Facial Injectables Market, by Collagen, 2019-2032 (USD Billion)
  • 5.4. Hyaluronic Acid (HA)
    • 5.4.1. Australia Facial Injectables Market, by Hyaluronic Acid (HA), 2019-2032 (USD Billion)
  • 5.5. Botulinum Toxin Type A
    • 5.5.1. Australia Facial Injectables Market, by Botulinum Toxin Type A, 2019-2032 (USD Billion)
  • 5.6. Calcium Hydroxylapatite (CaHA)
    • 5.6.1. Australia Facial Injectables Market, by Calcium Hydroxylapatite (CaHA), 2019-2032 (USD Billion)
  • 5.7. Polymer Fillers
    • 5.7.1. Australia Facial Injectables Market, by Polymer Fillers 2019-2032 (USD Billion)
    • 5.7.2. Polymethylmethacrylate Microspheres (PMMA)
      • 5.7.2.1. Australia Facial Injectables Market, by Polymethylmethacrylate Microspheres (PMMA) 2019-2032 (USD Billion)
    • 5.7.3. PLLA (Poly-L-lactic acid)
      • 5.7.3.1. Australia Facial Injectables Market, by PLLA (Poly-L-lactic acid), 2019-2032 (USD Billion)

6. Australia Facial Injectables Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Australia Facial Injectables Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Aesthetics
    • 6.3.1. Australia Facial Injectables Market, by Aesthetics, 2019-2032 (USD Billion)
  • 6.4. Therapeutics
    • 6.4.1. Australia Facial Injectables Market, by Therapeutics, 2019-2032 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. SILK Laser Clinics
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Advanced Clinics Australia
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Results Laser Clinic
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Australian Skin Clinics
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Laser Clinics Australia
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
Product Code: PM4330

List of Tables

  • Table 1 Australia Facial Injectables Market, by Application, 2019-2032 (USD Billion)
  • Table 2 Australia Facial Injectables Market, by Procedure Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1 Australia Facial Injectables Market, 2019-2032 (USD Billion)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Application
  • Figure 7 Australia Facial Injectables Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 8 Market by Procedure Type
  • Figure 9 Australia Facial Injectables Market, by Procedure Type, 2022 & 2032 (USD Billion)
  • Figure 10 Australia Facial Injectables Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 11 Strategic Analysis - Australia Facial Injectables Market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!